Tucatinib
Definition: Tucatinib, sold under the brand name Tukysa, is an anticancer medication used for the treatment of HER2-positive breast cancer. It is a small molecule inhibitor of HER2. It was developed by Array BioPharma and licensed to Cascadian Therapeutics (formerly Oncothyreon, subsequently part of Seattle Genetics). source: Wikipedia
- ID
- 871698009
- ID date
- 17 Jun 2022
- Previous ID
- 40229011000001101
- Name
- Tucatinib